Generics
Orion Pharma to commercialise pembrolizumab biosimilar in Europe
6 October 2026 - Finnish pharmaceutical company Orion Corporation (Orion Pharma) (HEL:ORNBV) announced on Tuesday an agreement with Qilu Pharma Europe to commercialise Qilu's intravenous (IV) pem...
Zydus and MSN announce US launch of generic Adempas (Riociguat Tablets)
6 October 2026 - India-based pharmaceutical companies Zydus Lifesciences Limited and MSN Laboratories Private Limited announced on Monday the launch of Riociguat Tablets, 0.5 mg, 1 mg, 1.5 mg, 2 mg an...
Renova Pharmaceuticals launches first three US generic products
11 September 2026 - Generic medicines developer Renova Pharmaceuticals LLC announced on Thursday the commercial launch of its first three FDA-approved generic products in the United States: L-Glutamin...
Prasco increases Ohio pharmaceutical footprint
1 September 2026 - Prasco LLC, a pharmaceutical commercialisation company specialising in authorised generics, today announced on Monday the acquisition of a strategically located distribution facilit...
Upsher-Smith launches Glatiramer Acetate Injection generic
21 August 2026 - Upsher-Smith Laboratories LLC, a US subsidiary of Bora Pharmaceuticals Co Ltd (TW:6472) (OTCQX:BORAY), announced on Thursday the launch of Glatiramer Acetate Injection in 20 mg/mL and...
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed Internatio...